Latest Insider Transactions at Masimo Corp (MASI)
This section provides a real-time view of insider transactions for Masimo Corp (MASI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MASIMO CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MASIMO CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2021
|
Micah W Young EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,087
-12.51%
|
$498,793
$239.0 P/Share
|
|
Apr 08
2021
|
Micah W Young EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,087
+11.12%
|
$179,482
$86.95 P/Share
|
|
Feb 22
2021
|
Micah W Young EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+50.0%
|
-
|
|
Feb 22
2021
|
Yongsam Lee EVP, CIO |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+13.74%
|
-
|
|
Feb 22
2021
|
Jon Coleman Pres-WW OEM & Global Health |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+34.04%
|
-
|
|
Feb 22
2021
|
Thomas Samuel Mc Clenahan EVP, GEN COUNSEL & CORP SEC |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+39.8%
|
-
|
|
Feb 22
2021
|
Anand Sampath EVP, Ops & Clinical Research |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+33.03%
|
-
|
|
Feb 22
2021
|
Tao Levy EVP, Bus Dev |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+50.0%
|
-
|
|
Feb 22
2021
|
Bilal Muhsin Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,593
+50.0%
|
-
|
|
Feb 22
2021
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
145,944
+30.98%
|
-
|
|
Jan 12
2021
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
3,403
-4.06%
|
$952,840
$280.32 P/Share
|
|
Jan 11
2021
|
Craig B Reynolds Director |
SELL
Open market or private sale
|
Direct |
10,000
-69.93%
|
$2,790,000
$279.74 P/Share
|
|
Jan 11
2021
|
Craig B Reynolds Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+41.15%
|
$230,000
$23.04 P/Share
|
|
Jan 11
2021
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
9,034
-9.73%
|
$2,529,520
$280.45 P/Share
|
|
Jan 08
2021
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
52,698
-36.21%
|
$14,808,138
$281.93 P/Share
|
|
Jan 07
2021
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
1,542
-1.05%
|
$431,760
$280.05 P/Share
|
|
Jan 02
2021
|
Anand Sampath EVP, Ops & Clinical Research |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-4.98%
|
$210,648
$268.38 P/Share
|
|
Jan 02
2021
|
Anand Sampath EVP, Ops & Clinical Research |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.25%
|
-
|
|
Jan 02
2021
|
Thomas Samuel Mc Clenahan EVP, GEN COUNSEL & CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-9.51%
|
$210,648
$268.38 P/Share
|
|
Jan 02
2021
|
Thomas Samuel Mc Clenahan EVP, GEN COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+19.49%
|
-
|
|
Jan 02
2021
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.04%
|
-
|
|
Jan 02
2021
|
Jon Coleman Pres-WW OEM & Global Health |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-5.43%
|
$210,648
$268.38 P/Share
|
|
Jan 02
2021
|
Jon Coleman Pres-WW OEM & Global Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+12.15%
|
-
|
|
Jan 02
2021
|
Yongsam Lee EVP, CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.53%
|
-
|
|
Dec 28
2020
|
Jon Coleman Pres-WW OEM & Global Health |
SELL
Open market or private sale
|
Direct |
8,250
-39.83%
|
$2,178,000
$264.02 P/Share
|
|
Dec 28
2020
|
Jon Coleman Pres-WW OEM & Global Health |
BUY
Exercise of conversion of derivative security
|
Direct |
8,250
+28.48%
|
$255,750
$31.01 P/Share
|
|
Dec 15
2020
|
Anand Sampath EVP, Ops & Clinical Research |
SELL
Open market or private sale
|
Direct |
30,000
-52.12%
|
$7,950,000
$265.59 P/Share
|
|
Dec 15
2020
|
Anand Sampath EVP, Ops & Clinical Research |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+34.26%
|
$780,000
$26.39 P/Share
|
|
Dec 11
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
6,038
-3.65%
|
$1,636,298
$271.31 P/Share
|
|
Dec 11
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
6,038
+3.52%
|
$169,064
$28.03 P/Share
|
|
Dec 10
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
36,626
-18.7%
|
$9,889,020
$270.5 P/Share
|
|
Dec 10
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
36,626
+15.75%
|
$1,025,528
$28.03 P/Share
|
|
Dec 09
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
1,365
-0.85%
|
$368,550
$270.33 P/Share
|
|
Dec 09
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
1,365
+0.84%
|
$38,220
$28.03 P/Share
|
|
Dec 08
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
55,971
-26.01%
|
$15,112,170
$270.68 P/Share
|
|
Dec 08
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
55,971
+20.64%
|
$1,567,188
$28.03 P/Share
|
|
Dec 04
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
11,688
-6.84%
|
$3,050,568
$261.5 P/Share
|
|
Dec 04
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
11,688
+6.4%
|
$327,264
$28.03 P/Share
|
|
Dec 03
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
88,312
-35.67%
|
$23,226,056
$263.13 P/Share
|
|
Dec 03
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
88,312
+26.29%
|
$2,472,736
$28.03 P/Share
|
|
Nov 03
2020
|
Thomas Harkin Director |
SELL
Bona fide gift
|
Direct |
1,845
-24.01%
|
-
|
|
Oct 27
2020
|
Joe E Kiani CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
47,508
-22.98%
|
$11,877,000
$250.47 P/Share
|
|
Oct 27
2020
|
Joe E Kiani CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
47,508
+18.69%
|
$1,330,224
$28.03 P/Share
|
|
Oct 27
2020
|
Craig B Reynolds Director |
SELL
Open market or private sale
|
Direct |
10,000
-69.93%
|
$2,500,000
$250.0 P/Share
|
|
Oct 27
2020
|
Craig B Reynolds Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+41.15%
|
$230,000
$23.04 P/Share
|
|
Oct 19
2020
|
Micah W Young EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$2,390,000
$239.0 P/Share
|
|
Oct 19
2020
|
Micah W Young EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$840,000
$84.97 P/Share
|
|
Oct 12
2020
|
Craig B Reynolds Director |
SELL
Open market or private sale
|
Direct |
20,000
-69.93%
|
$4,800,000
$240.1 P/Share
|
|
Oct 12
2020
|
Craig B Reynolds Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.15%
|
$460,000
$23.04 P/Share
|
|
Oct 07
2020
|
Bilal Muhsin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$6,275,000
$251.0 P/Share
|